Chlorhexidine digluconate (CHDG) is a widely used antiseptic and disinfectant that has become a cornerstone in infection prevention across multiple medical and dental applications. This versatile compound offers broad-spectrum antimicrobial activity with unique properties that have established it as an essential agent in healthcare settings worldwide. This article provides a detailed exploration of its chemical properties, mechanisms of action, clinical applications, and safety profile.
Introduction
Chlorhexidine digluconate, often referred to simply as chlorhexidine, is a powerful antiseptic and disinfectant that came into medical use in the 1950s. Developed by Imperial Chemical Industries in the United Kingdom, it was first introduced commercially in 1954 as a disinfectant and topical antiseptic. Since then, it has gained widespread acceptance and is now available over the counter in the United States.
Its clinical significance is highlighted by its inclusion in the World Health Organization’s List of Essential Medicines, underscoring its importance in global healthcare. As of 2022, it ranked as the 230th most commonly prescribed medication in the United States, with more than 1 million prescriptions issued annually.
The popularity of chlorhexidine digluconate stems from its remarkable effectiveness against a wide range of microorganisms, combined with its excellent safety profile and persistent antimicrobial action. It is used in various formulations, including solutions, gels, and impregnated medical devices, making it versatile for numerous clinical applications from surgical site preparation to oral healthcare.
Chemical Structure
Chlorhexidine digluconate has the molecular formula C22H30Cl2N10.2C6H12O7 and a molecular weight of 897.76. Chemically, it is known as 1,1′-(hexamethylene)bis[5-(4-chlorophenyl)biguanide] di-d-gluconate. The structure consists of two chlorophenyl biguanide groups connected by a hexamethylene chain, forming a symmetric molecule.
Chlorhexidine itself is a bisbiguanide that is insoluble in water. To enhance its solubility for clinical use, it is formulated with either gluconic or acetic acid to form water-soluble digluconate or diacetate salts. In its pure form, chlorhexidine solutions are colorless, odorless, and have an extremely bitter taste. It is a strong base and exists as a di-cation at physiological pH, which is significant for its mechanism of action.
The digluconate salt form is particularly advantageous for medical applications due to its superior water solubility compared to other salt forms, allowing for a wide range of formulation options across different concentrations and delivery systems.
Chlorhexidine-Based Medicines
Chlorhexidine digluconate is available in numerous commercial formulations across various therapeutic categories. The top eight widely used chlorhexidine-based medicines include:
- Betasept – A topical antiseptic solution for skin preparation before surgery
- ChloraPrep – A combination of chlorhexidine and alcohol for surgical site preparation
- Peridex/PerioGard – 0.12% oral rinse solutions for treating gingivitis
- Paroex – Dental solution for oral hygiene and gum disease prevention
- BioPatch – Chlorhexidine-impregnated dressing for catheter sites
- Chlorhexidine-impregnated PICC lines – Peripherally inserted central catheters with antimicrobial protection
- Chlorhexidine-coated surgical scrubs – For healthcare worker hand hygiene
- Umbilical cord care products – 7.1% chlorhexidine digluconate solution or gel for newborns
These products represent a fraction of the more than 60 pharmaceuticals and medical devices that incorporate chlorhexidine, demonstrating the compound’s versatility and widespread acceptance in clinical practice.
Mechanism of Action
Chlorhexidine digluconate’s antimicrobial efficacy stems from its unique mode of action against microbial cell membranes. The mechanism occurs in several stages that depend on the concentration of the compound and the exposure time.
The process begins with the attraction of positively charged chlorhexidine molecules to negatively charged bacterial cell surfaces containing phosphates and sulfate groups. This cationic property results in strong adsorption to phosphate-containing components on the bacterial cell surface. After the initial binding, chlorhexidine penetrates through the bacterial cell wall via passive diffusion, moving toward the cytoplasmic membrane.
At bacteriostatic (lower) concentrations, chlorhexidine disrupts the integrity of the cell membrane, increasing its permeability and causing leakage of low-molecular-weight cellular components such as potassium ions. This leads to inhibition of membrane-associated enzymes and disruption of cellular metabolism. At this stage, the antimicrobial action remains reversible if the chlorhexidine is removed.
At bactericidal (higher) concentrations, chlorhexidine causes more extensive damage. It enters the cell and precipitates cytoplasmic contents by forming complexes with phosphorylated compounds like adenosine triphosphate and nucleic acids. This precipitation of intracellular components results in cell death. The entire process from initial binding to cell death occurs rapidly, with bactericidal effects observed within seconds to minutes of exposure to adequate concentrations.
Due to its positive charge, chlorhexidine also exhibits good adherence to negatively charged oral surfaces (including mucous membranes, teeth, and salivary glycoproteins), providing prolonged antimicrobial activity (substantivity) for up to 12 hours after application.
Pharmacokinetics
Chlorhexidine digluconate’s pharmacokinetic profile is characterized by minimal systemic absorption, which contributes to its favorable safety profile in topical applications. When applied topically to intact skin or mucous membranes, chlorhexidine is unlikely to undergo significant systemic absorption.
When used topically, chlorhexidine binds covalently to proteins in the skin and mucosa through its N-chlorinated derivative, resulting in a persistent antimicrobial effect that continues even after the visible product has been removed. This property, known as substantivity, allows chlorhexidine to maintain antibacterial activity for extended periods after application.
Orally administered chlorhexidine, such as that found in mouthwashes and dental rinses, is very poorly absorbed from the gastrointestinal tract. Even in cases of accidental ingestion, systemic absorption remains minimal, further enhancing its safety profile for oral applications.
The limited systemic absorption of chlorhexidine is beneficial from a safety perspective, as it minimizes the potential for systemic toxicity and adverse effects. This characteristic makes it particularly suitable for repeated use in clinical settings where regular antisepsis is required, such as dental care and routine hospital hygiene protocols.
Therapeutic Uses
Chlorhexidine digluconate has found applications across numerous medical and dental fields. Its broad antimicrobial spectrum and safety profile have made it a preferred choice for various clinical situations. The table below summarizes the major therapeutic uses of chlorhexidine digluconate:
| Application Area | Specific Uses | Concentration/Formulation |
|---|---|---|
| Surgical Care | Skin preparation before surgery | 0.5-2% solution, often with alcohol |
| Surgical instrument disinfection | Various concentrations | |
| Hand antisepsis for surgical staff | 4% scrub formulations | |
| Wound Management | Cleaning wounds | 0.05-0.5% solutions |
| Antiseptic dressings | 0.5% chlorhexidine acetate ointment | |
| Dental/Oral Care | Treatment of gingivitis | 0.12% oral rinse |
| Prevention of dental plaque | 0.12-0.2% mouthwash | |
| Treatment of oral candidiasis | 0.12-0.2% oral solutions | |
| Catheter Care | Skin preparation for insertion | 2% solution with alcohol |
| Impregnated catheter dressings | 2% impregnated dressings | |
| Prevention of catheter blockage | Various formulations | |
| Neonatal Care | Umbilical cord care | 7.1% solution or gel (4% free chlorhexidine) |
| General Antisepsis | Hand hygiene in healthcare | 0.5-4% solutions or foams |
| Patient preoperative bathing | 2-4% body washes | |
| General skin disinfection | 0.5-4% solutions |
Chlorhexidine digluconate is particularly valuable in settings requiring prolonged antimicrobial activity and where other antiseptics might be inactivated, such as in the presence of blood or organic matter. Its use in umbilical cord care is especially important in high neonatal mortality settings, where it can significantly reduce infection rates.
Antimicrobial Spectrum
Chlorhexidine digluconate demonstrates impressive broad-spectrum antimicrobial activity against various pathogens. It is effective against both gram-positive and gram-negative bacteria, although gram-positive organisms tend to be more susceptible. Studies have shown that a 0.1% aqueous solution of chlorhexidine is bactericidal against Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa within 15 seconds of exposure.
The antimicrobial efficacy extends beyond bacteria to include yeasts and fungi. Chlorhexidine is also effective against many viruses, particularly lipophilic-enveloped viruses such as human immunodeficiency virus (HIV), influenza A, parainfluenza, hepatitis B, herpes simplex virus, and cytomegalovirus.
However, chlorhexidine has limited activity against bacterial spores, acid-fast bacilli, and some gram-negative organisms. It is also important to note that nosocomial infections due to Pseudomonas-contaminated chlorhexidine solutions have been reported, highlighting the importance of proper formulation and storage of chlorhexidine products.
Unlike some other antiseptics, such as povidone-iodine, chlorhexidine maintains its antimicrobial efficacy in the presence of blood and organic matter, making it particularly valuable in surgical settings and wound care.
Side Effects
Despite its generally favorable safety profile, chlorhexidine digluconate is associated with several side effects that clinicians and patients should be aware of. The most commonly reported adverse effects are related to its use in oral care products.
Tooth discoloration is a frequently observed side effect of chlorhexidine oral rinses, particularly with extended use. This staining effect is not universal and appears to be more significant with longer-term therapy (up to 6 months). The discoloration typically affects both teeth and dental restorations and may require professional cleaning to remove.
Taste disturbances, including a persistent bitter metallic aftertaste, are commonly reported by patients using chlorhexidine oral rinses. This unpleasant taste sensation can affect compliance with treatment regimens. Importantly, rinsing with water after using chlorhexidine mouthwash is not recommended as it can actually intensify the bitter taste.
Mucosal irritation, manifesting as soreness of the mouth or throat and tongue irritation, has been reported in clinical studies. In one trial, 31% of subjects using chlorhexidine mouthrinse reported adverse events, with taste changes, tooth staining, oral soreness, and tongue irritation being most common.
Allergic reactions ranging from mild contact dermatitis to severe anaphylaxis can occur with chlorhexidine use, though they are relatively uncommon. The incidence of contact dermatitis related to chlorhexidine in atopic patients is approximately 2.5 to 5.4%. It’s worth noting that acute hypersensitivity reactions to chlorhexidine are often not recognized and may be underreported.
Respiratory symptoms, including wheezing and shortness of breath, have been reported in some patients following exposure to chlorhexidine products. These symptoms may occur more commonly in those with pre-existing respiratory conditions.
Drug Interactions
Understanding the potential interactions between chlorhexidine digluconate and other substances is crucial for optimizing its effectiveness in clinical practice. Due to its cationic nature, chlorhexidine forms salts of low solubility when it interacts with anions such as phosphate, sulfate, and carboxyl groups.
The most clinically significant interaction is with anionic compounds, including most soaps and detergents. Toothpastes typically contain anionic detergents, with sodium lauryl sulfate (SLS) being one of the most widely used. Research has demonstrated that SLS can significantly reduce the antimicrobial efficacy of chlorhexidine, even when these compounds are used separately but in close sequence.
A study examining the interference of SLS on the antiplaque potential of chlorhexidine found that even a 30-minute interval between using SLS-containing products and chlorhexidine rinses resulted in significantly reduced antiplaque effects of chlorhexidine.
The neutralizing effect of SLS on chlorhexidine was found to disappear after approximately 2 hours. Therefore, it is recommended that patients wait at least 30 minutes between brushing with conventional toothpaste and using chlorhexidine mouthwash to avoid compromising its effectiveness.
Additionally, chlorhexidine’s activity can be enhanced by alcohols and quaternary ammonium compounds, while it may be somewhat depressed by high concentrations of organic matter (such as pus or blood), hard water, and contact with cork. These factors should be considered when using chlorhexidine in various clinical settings to ensure optimal antimicrobial efficacy.
Safety Considerations
While chlorhexidine digluconate is generally regarded as safe for most applications, several important safety considerations should guide its clinical use. Understanding these concerns is essential for maximizing benefits while minimizing risks.
Ocular exposure to chlorhexidine should be strictly avoided, as it can cause corneal damage. Care should be taken during facial applications, particularly around the eyes, and thorough rinsing should be performed if accidental contact occurs.
Ototoxicity is another concern with chlorhexidine. It should not come into contact with the middle ear as it can cause damage to ear structures. This is particularly important to consider during head and neck surgeries or procedures involving the ear canal.
Pregnant women can generally use chlorhexidine safely, as evidence suggests that topical use during pregnancy poses minimal risk. However, as with any medication during pregnancy, the benefits should be weighed against potential risks.
Healthcare professionals should be vigilant for signs of hypersensitivity reactions in patients exposed to chlorhexidine. These reactions can range from mild skin irritation to severe anaphylaxis. Patients with a history of allergic reactions to chlorhexidine should avoid further exposure, and alternative antiseptics should be considered.
Long-term use of chlorhexidine oral rinses may lead to staining of teeth and tongue, along with taste alterations. Patients should be informed of these potential effects before initiating treatment, and regular dental check-ups are recommended to monitor and address any staining issues.
When used in neonates, particularly for umbilical cord care, the appropriate concentration (7.1% chlorhexidine digluconate solution or gel, delivering 4% free chlorhexidine) should be used according to guidelines. For premature infants born at less than 32 weeks’ gestation or weighing less than 1,500g, special dosing considerations may apply.
Regulatory Status
Chlorhexidine digluconate holds a prominent position in healthcare systems worldwide, as evidenced by its regulatory status across different countries and international organizations. The World Health Organization (WHO) has included chlorhexidine on its List of Essential Medicines, recognizing its critical importance in healthcare systems globally. This designation highlights chlorhexidine’s role as one of the safest and most effective medicines needed in a functioning health system.
In the United States, chlorhexidine products are widely available, with many formulations accessible over the counter without a prescription. However, certain applications, particularly higher-concentration products or specialized medical devices impregnated with chlorhexidine, may require a prescription. As of 2022, it ranked as the 230th most commonly prescribed medication in the United States, with more than 1 million prescriptions issued annually.
The UN Commission on Life-Saving Commodities for Women and Children has identified chlorhexidine as one of 13 lifesaving commodities for women and children, particularly for its use in umbilical cord care in newborns. This recognition has led to increased availability of 7.1% chlorhexidine digluconate products in high-mortality settings.
Chlorhexidine’s inclusion in the WHO Model List of Essential Medicines for Children (EMLc) under Specific Medicines for Neonatal Care further emphasizes its importance in pediatric healthcare. This designation helps guide national formulary decisions and promotes access to this important antiseptic agent in resource-limited settings.
In the United Kingdom, where chlorhexidine was first developed and commercially introduced in 1954, it continues to be widely used across healthcare settings and is available in numerous formulations for both professional and consumer use.
Historical Development
The development of chlorhexidine represents a significant milestone in antiseptic history. Chlorhexidine was first synthesized by scientists at Imperial Chemical Industries (ICI) in the United Kingdom during the 1950s, as part of a program to develop antimalarial agents. Although it did not prove effective against malaria, researchers discovered its remarkable antiseptic properties.
The compound was first introduced commercially in the United Kingdom in 1954 as a disinfectant and topical antiseptic under the trade name “Hibitane”. An article published that same year by Imperial Chemical Industries, entitled “1:6-Di-4′-Chlorophenyldiguanidohexane (‘Hibitane’). Laboratory Investigation of a New Antibacterial Agent of High Potency,” outlined the promising antimicrobial potential of this new compound.
It wasn’t until the 1970s that chlorhexidine made its way to the United States, where it gradually gained acceptance across various medical specialties. Since its introduction, the applications for chlorhexidine have continued to expand as new formulations and delivery methods have been developed.
In 2010, two significant innovations expanded chlorhexidine’s utility in infection prevention: the first chlorhexidine-impregnated needleless connectors and the first chlorhexidine-impregnated Peripherally Inserted Central Catheter (PICC) were cleared by the FDA. These developments represented important advances in the prevention of catheter-related bloodstream infections, a significant cause of healthcare-associated infections.
Over nearly seven decades of clinical use, chlorhexidine has been incorporated into more than 60 pharmaceuticals and medical devices, demonstrating its versatility and enduring value in healthcare. Despite being in use for such an extended period, new applications for chlorhexidine continue to emerge, highlighting its ongoing importance in modern medicine.
Conclusion
Chlorhexidine digluconate stands as one of the most versatile and widely used antiseptic agents in modern healthcare. From its development in the 1950s to its current status as an essential medicine, chlorhexidine has proven its value across numerous clinical applications. Its unique mechanism of action, broad antimicrobial spectrum, persistent activity, and favorable safety profile have made it an indispensable tool in infection prevention and control.
The compound’s effectiveness against a wide range of pathogens, combined with its ability to maintain activity in the presence of organic matter, gives it advantages over many other antiseptic agents. Its various formulations-from oral rinses to surgical scrubs and impregnated medical devices-demonstrate its adaptability to different clinical needs.
While side effects such as tooth staining and taste alterations can occur, particularly with oral applications, these are generally manageable and must be weighed against the significant benefits of infection prevention. Understanding potential drug interactions, particularly with anionic detergents like sodium lauryl sulfate, is important for optimizing chlorhexidine’s effectiveness in clinical practice.
As antimicrobial resistance continues to pose challenges to global healthcare, the role of effective antiseptics like chlorhexidine in preventing infections becomes increasingly important. Ongoing research continues to explore new applications and formulations that may further expand chlorhexidine’s utility in healthcare settings around the world.
